أعرض في EDS

Patisiran, an RNAi therapeutic for patients with hereditary transthyretin‐mediated amyloidosis: Sub‐analysis in Japanese patients from the APOLLO study

التفاصيل البيبلوغرافية
العنوان: Patisiran, an RNAi therapeutic for patients with hereditary transthyretin‐mediated amyloidosis: Sub‐analysis in Japanese patients from the APOLLO study
المؤلفون: Matthew T. White, Masahisa Katsuno, Jing Jing Wang, Taro Yamashita, Mitsuharu Ueda, Tsuneaki Yoshinaga, Yoshiki Sekijima, Marianne T. Sweetser, Gen Sobue, Yukio Ando, Haruki Koike, Xiaoping Zhang, Minori Kodaira
المصدر: Neurology and Clinical Neuroscience. 8:251-260
بيانات النشر: Wiley, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Pathology, medicine.medical_specialty, biology, business.industry, Amyloidosis, medicine.disease, Transthyretin, Neurology, RNA interference, medicine, biology.protein, Neurology (clinical), business, Polyneuropathy, Attr amyloidosis
تدمد: 2049-4173
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1ce5b2f8eb0cedd5b6c483c79f2c3022Test
https://doi.org/10.1111/ncn3.12396Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........1ce5b2f8eb0cedd5b6c483c79f2c3022
قاعدة البيانات: OpenAIRE
الوصف
تدمد:20494173